Lisata Therapeutics Inc. (NASDAQ: LSTA) — Healthcare · Share Price, Chart & Market Data
About: Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.22 (+0.63%)
LSTALisata Therapeutics Inc.
Loading watchlist status…
Trade LSTA now
Lisata Therapeutics Inc. share price
LSTA price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
30 Apr, 6:44 am GMT+0
LSTA price performance
-3.303%
5D
-35.729%
1M
64.286%
YTD
31.493%
1Y
LSTA price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
30 Apr, 6:44 am GMT+0
LSTA details
LSTA Market Signals